Search - tctmd.com

Displaying 1 - 20 of 280

Sort: Relevancy | Date

News Conference News ACC 2026

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

L.A. McKeown

April 08, 2026

News Conference News ACC 2026

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

Michael O'Riordan

April 06, 2026

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

L.A. McKeown

March 26, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Daily News

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

Todd Neale

February 10, 2026

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

Todd Neale

December 23, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

Advertisement

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

March 2026 Dispatch for the CV Team

What’s Going to Be Hot at ACC 2026

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Heart Disease Remains Number One Killer of Americans

HF Care Differs Among Asian Subgroups in the US

JACC Debuts Data Digest on CV Health in the United States

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Year in Review: Evidence Around AI in Cardiology Grows

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

October 2025 Dispatch for the CV Team

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

What’s Going to Be Hot at ESC Congress 2025?

August 2025 Dispatch for the CV Team

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content